A National Institutes of Health study based in rural Guatemala is seeking to discover how the Zika virus affects infants and young children.

A team is researching the way skin microbes can affect the skin's health and contribute to problems like from acne and skin cancer, according to the American Cancer Society (ACS).

Mindstrong Health, a startup focused on using smartphones to diagnose and aid in in the treatment of neuropsychiatric disorders, said it has secured $14 million in Series-A funding from investors that included Foresite Capital, ARCH Venture Partners, Optum Ventures and One Mind Brain Health Impact Fund.

Adient, formerly known as Johnson Controls, said platform director Tom O'Brien was honored as the Father of the Year at the recent American Diabetes Association (ADA) Awards.

Hopebridge, the largest provider of applied behavior analysis (ABA) services for autistic and developmentally delayed children in Indiana, said it will expand into Kentucky and open new clinics later this year.

Skepticism is already being expressed ahead of the Congressional Budget Office release of its score card on the Senate health care bill.

Treating certain types of skin cancer with two Novartis drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), allows patients to survive cancer-free up to five years, according to a breakthrough study.

Aspirin has been used for many years to reduce the risk of cardiovascular problems such as stroke and heart attack by cutting down on blood clots, but a University of Florida Health team of researchers has recently found that it may offer little to no benefit for some patients who have plaque built up in their arteries.

In a move that could help open the U.S. market for biosimilars, a U.S. Food and Drug Administration subcommittee recently greenlighted Pfizer Inc.’s epoetin alfa compound, an emulation of two medicines designed to relieve anemia in patients who have cancer and kidney disease.

Patients suffering from an undetected irregular heartbeat are more likely to suffer strokes than those whose who have a treated heart condition, according to a study conducted by the German pharmaceutical company Boehringer Ingelheim.

Dungarvin Inc. said Dungarvin Ohio LLC has acquired Embracing Autism, a highly regarded Ohio program that provides services for families with children and adults with autism and other disorders.

Patients suffering from arthritis may benefit from being part of a patient support group, according to a study conducted by AbbVie Inc., a Chicago-based pharmaceutical company that manufactures the arthritis drug Humira.

Based on data from an international clinical trial, U.S. drugmaker Amgen has petitioned the Food and Drug Administration to allow use of Xgeva (denosumab) to prevent bone fractures among multiple myeloma patients.

The likelihood of surviving cancer is going up, and new treatment therapies are to thank, a posting on the Pharmaceutical Research and Manufacturers of America website said.

The Agency for Healthcare Research and Quality (AHRQ) said it has found ways to cut down on sensory and motor problems in children with autism spectrum disorder (ASD).

AstraZeneca and its global biologics research and development arm, MedImmune, said the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Imfinzi (durvalumab).

Shire said results of study show lanadelumab cut down on the rate of monthly hereditary angioedema episodes by 87 percent.

The ALS Association has joined the Muscular Dystrophy Association and the Les Turner ALS Foundation in opposing a plan that would eliminate federal funding for the Centers for Disease Control and Prevention's National ALS Registry.

The Ohio State University Comprehensive Cancer Center said two drugs approved by the U.S. Food and Drug Administration (FDA) to treat melanoma may also be effective against some aggressive forms of papillary thyroid cancer.

GlaxoSmithKline (GSK) said results of a recent study showed that Nucala (mepolizumab) is effective in helping certain patients deal with asthma.